1ABBV:BIT
AbbVie
230,10 €
arrow_downward
-0,60%(-1,40) 1K
2-okt, 17:26:00 (GMT+2) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto1ABBV tikeri uchun statistika yaratilmoqda...
Ochish
232,20 €
Yuqori
232,20 €
Past
230,10 €
Bozor kapitali
496,77 mlrd
Oʻrtacha hajm
38,00
Hajmi
26,00
52 haftalik eng yuqori
234,90 €
52 haftalik eng past
168,00 €
Xodimlar soni
57 ming
Ochish
232,20 €
Yuqori
232,20 €
Past
230,10 €
Bozor kapitali
496,77 mlrd
Oʻrtacha hajm
38,00
Hajmi
26,00
52 haftalik eng yuqori
234,90 €
52 haftalik eng past
168,00 €
Xodimlar soni
57 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Seeking Alpha
·
1 soat oldin
AbbVie, Eli Lilly among mega-cap healthcare stocks with A+ profitability grades (XLV:NYSEARCA)
Endpoints News
·
2 soat oldin
After $10.9B exit to AbbVie, Apogee execs join Paragon to scale its R&D, company creation engine
Yahoo Finance
·
5 soat oldin
AbbVie (ABBV) Could Be 44% Below Fair Value On Fresh Pipeline Wins
ad-hoc-news.de
·
6 soat oldin
AbbVie presents 22 IBD abstracts: stock at EUR 253.15 pre-market
Profil
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
AbbVie haqida
CEORobert A. Michael
Xodimlar soni57 ming
Asos solingan10-apr, 2012
Bosh ofislarNorth Chicago, Illinoys, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytabbvie.com